LY3857210

LY3857210 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY3857210, covering 2024-06-26 to 2024-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain [Phase 2]